Journal of Clinical Oncology, 0732-183X

Journal

More filtering options
  1. Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA).

    Tandstad, T., Smaaland, R., Solberg, A., Bremnes, R. M., Langberg, C. W., Laurell, A., Stierner, U. K., Ståhl, O., Cavallin-Ståhl, E., Klepp, O. H., Dahl, O. & Cohn-Cedermark, G., 2011, In : Journal of Clinical Oncology. 29, 4, p. 719-725

    Research output: Contribution to journalArticle

  2. Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program.

    Tandstad, T., Dahl, O., Cohn-Cedermark, G., Cavallin-Ståhl, E., Stierner, U., Solberg, A., Langberg, C., Bremnes, R. M., Laurell, A., Wijkstrøm, H. & Klepp, O., 2009, In : Journal of Clinical Oncology. 27, p. 2122-2128

    Research output: Contribution to journalArticle

  3. Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.

    Tanner, M., Isola, J., Wiklund, T., Erikstein, B., Kellokumpu-Lehtinen, P., Per Malmström, Wilking, N., Nilsson, J. & Bergh, J., 2006, In : Journal of Clinical Oncology. 24, 16, p. 2428-2436

    Research output: Contribution to journalArticle

  4. Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.

    Tanner, MM., Isola, JJ., Wiklund, T., Erikstein, B., Kellokumpu-Lehtinen, P., Per Malmström, Wilking, N., Nilsson, J. & Bergh, J., 2005, In : Journal of Clinical Oncology. 23, 16S, p. 841S-841S

    Research output: Contribution to journalPublished meeting abstract

  5. International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.

    Terpos, E., Morgan, G., Dimopoulos, M. A., Drake, M. T., Lentzsch, S., Raje, N., Sezer, O., García-Sanz, R., Shimizu, K., Ingemar Turesson, Reiman, T., Jurczyszyn, A., Merlini, G., Spencer, A., Leleu, X., Cavo, M., Munshi, N., Rajkumar, S. V., Durie, B. G. M. & Roodman, G. D., 2013, In : Journal of Clinical Oncology. 31, 18, p. 2347-U179

    Research output: Contribution to journalArticle

  6. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors

    Timmerman, D., Van Calster, B., Jurkovic, D., Lil Valentin, Testa, A. C., Bernard, J-P., Van Holsbeke, C., Van Huffel, S., Vergote, I. & Bourne, T., 2007, In : Journal of Clinical Oncology. 25, 27, p. 4194-4200

    Research output: Contribution to journalArticle

  7. Pitfalls of CA-125 levels in the preoperative work-up of ovarian masses - Reply

    Timmerman, D., Bourne, T., Amant, F., Van Holsbeke, C., Vergote, I., Testa, A. C., Van Calster, B., Van Huffel, S. & Lil Valentin, 2008, In : Journal of Clinical Oncology. 26, 3, p. 513-513

    Research output: Contribution to journalLetter

  8. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: A multicenter study by the International Ovarian Tumor Analysis Group

    Timmerman, D., Testa, AC., Bourne, T., Ferrazzi, E., Ameye, L., Konstantinovic, ML., Van Calster, B., Collins, WP., Vergote, I., Van Huffel, S. & Lil Valentin, 2005, In : Journal of Clinical Oncology. 23, 34, p. 8794-8801

    Research output: Contribution to journalArticle

  9. Models of care for survivors of childhood cancer from across the globe: Advancing survivorship care in the next decade

    Tonorezos, E. S., Barnea, D., Cohn, R. J., Cypriano, M. S., Fresneau, B. C., Haupt, R., Lars Hjorth, Ishida, Y., Kruseova, J., Kuehni, C. E., Kurkure, P. A., Langer, T., Nathan, P. C., Skeen, J. E., Skinner, R., Tacyildiz, N., Van Den Heuvel-Eibrink, M. M., Winther, J. F., Hudson, M. M. & Oeffinger, K. C., 2018 Jul 20, In : Journal of Clinical Oncology. 36, 21, p. 2223-2230 8 p.

    Research output: Contribution to journalReview article

  10. Parametric Response Map as a Potential Imaging biomarker for Distinguishing Progression fromPseudo-progression in High Grade gliomas.

    Tsien, C., Galbán, CJ., Chenevert, TL., Hamstra, DA., Pia Sundgren, Junck, L., Lawrence, T., Meyer, CR., Rehemtulla, A. & Ross, BD., 2010, In : Journal of Clinical Oncology. 28, 13, p. 2293-2299

    Research output: Contribution to journalArticle